Kindred Healthcare Inc. (NYSE:KND) shares were up 4% on Tuesday . The company traded as high as $10.90 and last traded at $10.84, with a volume of 395,740 shares changing hands. The stock had previously closed at $10.42.

A number of research analysts have weighed in on KND shares. Zacks Investment Research cut shares of Kindred Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, August 9th. Bank of America Corp. reissued a “sell” rating and set a $11.00 target price on shares of Kindred Healthcare in a research note on Friday, August 5th. Mizuho boosted their target price on shares of Kindred Healthcare from $9.00 to $13.50 and gave the stock a “neutral” rating in a research note on Thursday, May 5th. Finally, Avondale Partners cut their target price on shares of Kindred Healthcare from $17.00 to $14.00 and set a “market perform” rating for the company in a research note on Friday, June 17th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $13.57.

The stock’s 50 day moving average is $11.61 and its 200 day moving average is $11.77. The firm has a market capitalization of $886.63 million and a P/E ratio of 13.44.

Kindred Healthcare (NYSE:KND) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.34 by $0.04. The business had revenue of $1.84 billion for the quarter, compared to analysts’ expectations of $1.85 billion. During the same period in the previous year, the business posted $0.39 earnings per share. The company’s revenue for the quarter was up .5% on a year-over-year basis. Equities analysts expect that Kindred Healthcare Inc. will post $0.90 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 2nd. Stockholders of record on Thursday, August 18th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 4.62%. The ex-dividend date is Tuesday, August 16th.

In other news, CAO John Joseph Lucchese sold 4,341 shares of the firm’s stock in a transaction on Wednesday, June 29th. The shares were sold at an average price of $11.39, for a total value of $49,443.99. Following the completion of the sale, the chief accounting officer now owns 34,130 shares in the company, valued at approximately $388,740.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Other hedge funds have recently added to or reduced their stakes in the company. Morgan Stanley boosted its stake in Kindred Healthcare by 49.4% in the fourth quarter. Morgan Stanley now owns 1,189,407 shares of the company’s stock valued at $14,166,000 after buying an additional 393,128 shares during the period. Wells Fargo & Company MN boosted its stake in shares of Kindred Healthcare by 520.3% in the fourth quarter. Wells Fargo & Company MN now owns 863,118 shares of the company’s stock valued at $10,280,000 after buying an additional 723,970 shares during the period. Finally, Royce & Associates LLC boosted its stake in shares of Kindred Healthcare by 37.0% in the fourth quarter. Royce & Associates LLC now owns 185,000 shares of the company’s stock valued at $2,203,000 after buying an additional 50,000 shares during the period.

Kindred Healthcare, Inc is a healthcare services company. The Company operates through four divisions, including the hospital division, the Kindred at Home division, the Kindred Rehabilitation Services division and the nursing center division. Its divisions represent over six segments, including hospitals, home health services, hospice services, Kindred Hospital Rehabilitation Services, RehabCare and nursing centers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.